Targeted Genetics' intellectual property provides a strong foundation to attract corporate and academic partners and in turn, our partnerships validate our portfolio and strategies. We have a broad platform-based intellectual property portfolio which includes patents and patent applications covering vectors, formulations, methods of transferring genetic material into cells, processes to manufacture and purify our gene delivery product candidates and other proprietary technologies and processes. To date, we have been issued, filed or licensed numerous patents or patent applications with the United States Patent and Trademark Office (USPTO), including foreign counterparts of some of these applications in Europe, Japan and other countries. |
